Anna Maria Miscio

Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting

Antonio Santoro, Andrea Fontana, Anna Maria Miscio et al. · Neurological Sciences · 2017 · 28 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study

Raffaele Ornello, Fayyaz Ahmed, Andrea Negro et al. · Pain and Therapy · 2021 · 27 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Chronic migraine long-term regular treatment with onabotulinumtoxinA: a retrospective real-life observational study up to 4 years of therapy

Antonio Santoro, Massimiliano Copetti, Anna Maria Miscio et al. · Neurological Sciences · 2020 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors

Raffaele Ornello, Carlo Baraldi, Fayyaz Ahmed et al. · International Journal of Environmental Research and Public Health · 2022 · 20 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients

Raffaele Ornello, Fayyaz Ahmed, Andrea Negro et al. · Pain and Therapy · 2021 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16